Global Nicotinamide Riboside (NR) Market Strategic Research Report

Scope of the Report

Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.

In fact, the market’s mainstream is selling NRC powder, the full name called nicotinamide riboside chloride. NRC is a chloride form of NR. 100 mg of nicotinamide riboside chloride provides about 88 mg of nicotinamide riboside. The report focuses on the Nicotinamide Riboside(NR) market, which has been converted.

The global Nicotinamide Riboside (NR) market was valued at US$ 21.46 million in 2022 and will reach US$ 38.76 million by the end of 2029, growing at a CAGR of 8.32% during 2023-2029.

The data for 2023 is an estimate, based on the historical data and the integrated view of industrial experts, manufacturers, distributors, and end users, etc.

Top-down and bottom-up approaches are used to validate the global Nicotinamide Riboside (NR) market size and to estimate the market size for company, regional division, product type and application (end users). In the complete market engineering process, both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Global key players of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, etc. The top three players hold a share over 60%.

Asia-Pacific is the largest market, has a share about 39%, followed by North America, and Europe, with share 35% and 16%, separately.

In terms of product type, purity below 98% is the largest segment, occupied for a share of 63%, and in terms of application, health supplement has a share about 92 percent.

This report presents a comprehensive overview of the global Nicotinamide Riboside (NR) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Purity ≤98%
• Purity ＞98%

Segment by Application

• Health Supplement
• Pharmaceutical Additives

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Nicotinamide Riboside (NR) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Health Supplement, Pharmaceutical Additives evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact